Literature DB >> 15457671

Sampling strategy for prostate tissue microarrays for Ki-67 and androgen receptor biomarkers.

Swaroop S Singh1, Bahjat Qaqish, Jacqueline L Johnson, O Harris Ford, Julie F Foley, Susan J Maygarden, James L Mohler.   

Abstract

OBJECTIVE: To develop an optimal sampling strategy for tissue microarrays using automated digital analysis for androgen receptor (heterogeneous expression) and the cellular proliferation marker Ki-67 (homogeneous expression and evaluated by others using nonautomated methods). STUDY
DESIGN: Tissue microarrays were constructed from 23 radical prostatectomy specimens and immunostained for androgen receptor expression and cellular proliferation. Automated digital image analysis was used, and the minimum number of cores necessary to capture variance change <3% was determined. Androgen receptor immunostaining was described by percent positive nuclei (PPN) and mean optical density (MOD).
RESULTS: Androgen receptor PPN variance measurements showed that 5 cores should be obtained when a single block of a radical prostatectomy specimen contained cancer. If all of 15 blocks contained cancer, 2 cores should be obtained from each of 6 blocks. An optimal sampling strategy was developed for androgen receptor PPN, androgen receptor MOD and Ki-67 PPN.
CONCLUSION: The selection of the number of cores to sample is a tradeoff between the number of cores available that contain cancer and the amount of work involved in the analysis. Sampling no fewer than 5 but no more than 12 cores per radical prostatectomy specimen can capture tissue heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15457671

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  7 in total

1.  Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer.

Authors:  Sara Jonmarker Jaraj; Philippe Camparo; Helen Boyle; François Germain; Bo Nilsson; Fredrik Petersson; Lars Egevad
Journal:  Virchows Arch       Date:  2009-09-18       Impact factor: 4.064

Review 2.  Histopathological image analysis: a review.

Authors:  Metin N Gurcan; Laura E Boucheron; Ali Can; Anant Madabhushi; Nasir M Rajpoot; B Yener
Journal:  IEEE Rev Biomed Eng       Date:  2009-10-30

3.  5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.

Authors:  Alejandro Godoy; Elzbieta Kawinski; Yun Li; Daizo Oka; Borislav Alexiev; Faris Azzouni; Mark A Titus; James L Mohler
Journal:  Prostate       Date:  2010-12-28       Impact factor: 4.104

4.  Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.

Authors:  John T Minges; Shifeng Su; Gail Grossman; Amanda J Blackwelder; Elena A Pop; James L Mohler; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-11-21       Impact factor: 5.157

Review 5.  Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer.

Authors:  Chih-Pin Chuu; John M Kokontis; Richard A Hiipakka; Junichi Fukuchi; Hui-Ping Lin; Ching-Yu Lin; Chiech Huo; Liang-Cheng Su
Journal:  J Biomed Sci       Date:  2011-08-23       Impact factor: 8.410

6.  Java Web Start based software for automated quantitative nuclear analysis of prostate cancer and benign prostate hyperplasia.

Authors:  Swaroop S Singh; Desok Kim; James L Mohler
Journal:  Biomed Eng Online       Date:  2005-05-11       Impact factor: 2.819

7.  Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.

Authors:  Hui-Ping Lin; Ching-Yu Lin; Ping-Hsuan Hsiao; Horng-Dar Wang; Shih Sheng Jiang; Jong-Ming Hsu; Wai-Tim Jim; Marcelo Chen; Hsing-Jien Kung; Chih-Pin Chuu
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.